Skip Nav Destination
Article navigation
Editorial Views|
February 1979
Rationale for Dantrolene vs.Procainamide for Treatment of Malignant Hyperthermia
Anesthesiology February 1979, Vol. 50, 118–122.
Citation
Thomas E. Nelson, Eugene H. Flewellen; Rationale for Dantrolene vs.Procainamide for Treatment of Malignant Hyperthermia . Anesthesiology 1979; 50:118–122 doi: https://doi.org/10.1097/00000542-197902000-00008
Download citation file:
Citing articles via
Most Viewed
Related Articles
Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review
Anesthesiology (January 2019)
Cost-effectiveness Analysis of Stocking Dantrolene in Ambulatory Surgery Centers for the Treatment of Malignant Hyperthermia
Anesthesiology (June 2014)
Cost-benefit Analysis of Maintaining a Fully Stocked Malignant Hyperthermia Cart versus an Initial Dantrolene Treatment Dose for Maternity Units
Anesthesiology (August 2018)
Malignant Hyperthermia Testing in Probands without Adverse Anesthetic Reaction
Anesthesiology (September 2015)
